MedTrace Logo

The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers

NCT00874003 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2009-04-02

No results posted yet for this study

Summary

The purpose of this study is to study the effects of 8 weeks of treatment with mirtazapine on alcohol consumption in alcohol high consuming men. This study is a randomized, double-blind placebo controlled clinical trial with parallel group design(N=59).

Conditions

  • Alcohol Dependence

Interventions

DRUG

mirtazapine

oral tablet, 30 mg daily

DRUG

placebo

oral tablet, 1 daily

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Andrea deBejczy, MD · Addiction Biology Unit

  • Bo Söderpalm, MD, PhD · Addiction Biology Unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-07-31
Completion
2009-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874003 on ClinicalTrials.gov